Canadian Space Technology Helps Breast Cancer Patients

The technology and expertise developed to build the first Canadarm not only paved the way for its descendants, Canadarm2 and Dextre, that are in great part responsible for the successful assembly and operating of the International Space Station, it also translated into new technology for the operating room.


The Centre for Surgical Innovation and Invention turned to Canadarm technology to develop IGAR (Image-Guided Autonomous Robot), a promising platform offering one stop diagnosis and treatment for patients with a high risk of breast cancer. Thanks to its delicate and precise touch, the robot will be able to perform biopsies with pinpoint accuracy, analyze them and treat early tumours without open surgeries.
Currently undergoing clinical trials, IGAR is one of the first robots of its kind designed to work inside an MRI scanner that can show the size and location of tumours more accurately than a mammogram or ultrasound scan. The platform will also help in detection and treatment of lung, liver, kidney and prostate cancers, and might also be used for delicate spinal surgeries.

MDA

About Marc Boucher

Marc Boucher
Boucher is an entrepreneur, writer, editor & publisher. He is the founder of SpaceQ Media Inc. and CEO and co-founder of SpaceRef Interactice Inc. Boucher has 18 years working in various roles in the space industry and a total of 25 years as a technology entrepreneur including creating Maple Square, Canada's first internet directory and search engine.

Check Also

The Honourable Navdeep Bains stands in front of the Canadarm2 Latching End Effector spare that will launch to the ISS in 2018.

Minister Bains Highlights Robotic and Lunar Technology Contributions to Canada’s Space Program

The Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development, made a stop today …